Alaunos Therapeutics Inc (TCRT)
2.03
-0.01
(-0.49%)
USD |
NASDAQ |
Nov 04, 12:58
Alaunos Therapeutics Shareholders Equity (Quarterly): 3.771M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 3.771M |
March 31, 2024 | 4.797M |
December 31, 2023 | 6.307M |
September 30, 2023 | 13.90M |
June 30, 2023 | 21.65M |
March 31, 2023 | 29.51M |
December 31, 2022 | 38.56M |
September 30, 2022 | 32.11M |
June 30, 2022 | 40.18M |
March 31, 2022 | 49.12M |
December 31, 2021 | 58.06M |
September 30, 2021 | 68.71M |
June 30, 2021 | 88.28M |
March 31, 2021 | 105.64M |
December 31, 2020 | 123.98M |
September 30, 2020 | 144.92M |
June 30, 2020 | 163.41M |
March 31, 2020 | 180.34M |
December 31, 2019 | 95.01M |
September 30, 2019 | 106.13M |
June 30, 2019 | 62.00M |
March 31, 2019 | 74.22M |
December 31, 2018 | 85.56M |
September 30, 2018 | 4.015M |
June 30, 2018 | 15.19M |
Date | Value |
---|---|
March 31, 2018 | 25.89M |
December 31, 2017 | 47.19M |
September 30, 2017 | 59.27M |
June 30, 2017 | 69.96M |
March 31, 2017 | 34.54M |
December 31, 2016 | 48.02M |
September 30, 2016 | 57.40M |
June 30, 2016 | -51.99M |
March 31, 2016 | 77.81M |
December 31, 2015 | 87.37M |
September 30, 2015 | 93.84M |
June 30, 2015 | 110.44M |
March 31, 2015 | 120.60M |
December 31, 2014 | 33.84M |
September 30, 2014 | 36.48M |
June 30, 2014 | 37.72M |
March 31, 2014 | 41.73M |
December 31, 2013 | 49.38M |
September 30, 2013 | 3.631M |
June 30, 2013 | 19.33M |
March 31, 2013 | 37.89M |
December 31, 2012 | 48.44M |
September 30, 2012 | 59.03M |
June 30, 2012 | 75.64M |
March 31, 2012 | 97.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.771M
Minimum
Jun 2024
180.34M
Maximum
Mar 2020
66.75M
Average
49.12M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Perspective Therapeutics Inc | 341.00M |
Oragenics Inc | 1.326M |
Cocrystal Pharma Inc | 17.39M |
Cara Therapeutics Inc | 11.60M |
Jaguar Health Inc | 16.91M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.678M |
Total Liabilities (Quarterly) | 0.907M |
Current Ratio | 5.158 |
Net Debt Paydown Yield | 19.63% |